Osteoporosis: Therapy in interface management;Osteoporose - Therapie und sektorenübergreifendes Management

Wiener Medizinische Wochenschrift

Volumn 163, Issue 19-20, 2013, Pages 455-461

  Mikosch, Peter ^a   Gosch, Markus ^b  

^a HANUSCH HOSPITAL   (Austria)

^b Abteilung fur Innere Medizin und Akutgeriatrie   (Austria)

Author keywords

Clinical management; Fractures; Osteoporosis; Start of therapy; Therapy

Indexed keywords

ARTICLE; FRAGILITY FRACTURE; GERIATRIC PATIENT; HUMAN; OSTEOPOROSIS;

AGED; AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; COOPERATIVE BEHAVIOR; EVIDENCE-BASED MEDICINE; HIP FRACTURES; HUMANS; INTERDISCIPLINARY COMMUNICATION; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SPINAL FRACTURES;

EID: 84889018680     PISSN: 00435341     EISSN: 1563258X     Source Type: Journal    
DOI: 10.1007/s10354-013-0238-9     Document Type: Article

References (34)

1. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285:785-95.
2. Mikosch P. Diagnosis of osteoporosis in geriatric patients - possibilities and limitations. Wien Med Wschr. 2012;162:99-109.
3. Bischoff-Ferrari H, Bohmer F, Broll H, Dovjak P, Gasser R, Krejs GJ, Leixnering M, Muller M, Pietschmann P, Pinter G, Talasz, Pils K, Resch H. Osteoporose 75 + Konsensus-Statement. CliniCum - Das Magazin fur die Fuhrungskrafte im Krankenhaus. Sonderausgabe September 2007. http://www.geriatrie-online.at/mm/mm006/Kons-Osteo-LOW.pdf.
4. Dachverband Osteologie e. V.: DVO-Leitlinie. Prophylaxe, Diagnostik und Therapie der Osteoporose bei Erwachsenen - Langfassung. Osteologie. 2009;18:304-28. http://www.dv-osteologie.org/dvo-leitlinien/dvo-leitlinie-2009.
5. Initiative Arznei & Vernunft, Vernunftiger Umgang mit Medikamenten: Osteoporose - Knochenbruchkrankheit, 3. Auflage Mai 2010.
6. Liu H, Paige NM, Goldzweig CL, Wong E, Zhou A, Suttorp MJ, Munjas B, Orwoll E, Shekelle P. Screening for osteoporosis in men: a systematic review for an American College of Physicians guideline. Ann Intern Med. 2008;148:685-701.
7. Pietschmann P, Azizi-Semrad U, Pils K, Fahrleitner-Pammer A, Resch H, Dobnig H. Pharmacologic undertreatment of osteoporosis in Austrian nursing homes and senior's residences. Wien Klin Wochenschr. 2010;122:532-7. doi:10.1007/s00508-010-1428-8.
8. Wright RM. Use of osteoporosis medications in older nursing facility residents. J Am Med Dir Assoc. 2007;8:453-7.
9. Haaland DA, Cohen DR, Kennedy CC, Khalidi NA, Adachi JD, Papaioannou A. Closing the osteoporosis care gap: increased osteoporosis awareness among geriatrics and rehabilitation teams. BMC Geriatr. 2009;9:28. doi:10.1186/1471-2318-9-28.
10. Metge CJ, Leslie WD, Manness LJ, Yogendran M, Yuen CK, Kvern B, Maximizing Osteoporosis Management in Manitoba Steering Committee. Postfracture care for older women: gaps between optimal care and actual care. Can Fam Physician. 2008;54:1270-6.
11. Giangregorio LM, Jantzi M, Papaioannou A, Hirdes J, Maxwell CJ, Poss JW. Osteoporosis management among residents living in long-term care. Osteoporos Int. 2009;20:1471-8.
12. Kamal HK. Secondary prevention of hip fractures among hospitalized elderly: are we doing enough? J Clin Rheumatol. 2005;11:68-71.
13. Jennings LA, Auerbach AD, Maselli J, Pekow PS, Lindenauer PK, Lee SJ. Missed opportunities for osteoporosis treatment in patients hospitalized for hip fracture. J Am Geriatr Soc. 2010 Apr;58:650-7.
14. Gosch M, Kammerlander C, Roth T, Luger T, Blauth M, Lechleitner M. Tiroler Zentrum fur Altersfrakturen - Traumatologisch-geriatrisches Komanagement: Erste Erfahrungen und Ergebnisse. J Miner Stoffwechs. 2011;18:7-12.
15. Sampl E, Dobnig H, Dimai H, Obermayer-Pietsch B, Pieber T, Fahrleitner-Pammer A. Aufbau eines "Fracture-Liaison"-Dienstes (FLD) in der Steiermark. J Miner Stoffwechs. 2011;18:13-16.
16. Mikosch P, Daskalakis S, Igerc I, Matschnig S, Jerusalem A, Muller EJ, Stockl B, Schauss S, Egarter K, Jeschofnik R, Geissler D, Lind P, Pinter G. Osteologische Konsiliarbetreuung im Klinikum Klagenfurt am Worthersee: Initiale Ergebnisse eines Pilotprojekts. J Miner Stoffwechs. 2011;18:17-23.
17. Gosch M, Roth T, Kammerlander C, Joosten-Gstrein B, Benvenuti-Falger U, Blauth M, Lechleitner M. Treatment of osteoporosis in postmenopausal hip fracture patients after geriatric rehabilitation: changes over the last decade. Z Gerontol Geriatr. 2011;44:381-6.
18. Dimai HP: Diagnostik der Osteoporose. Wien Med Wochenschr. 2009;159:241-6.
19. Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A; National Osteoporosis Guideline Group. Case finding for the management of osteoporosis with FRAX-assessment and intervention thresholds for the UK. Osteoporos Int. 2008;19:1395-408. doi: 10.1007/s00198-008-0712-1. Epub 2008 Aug 28.
20. Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY, on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2013;24:23-57.
21. Curtis JR, Arora T, Matthews RS, Taylor A, Becker DJ, Colon-Emeric C, Kilgore ML, Morrisey MA, Saag KG, Safford MM, Warriner A, Delzell E. Is withholding osteoporosis medication after fracture sometimes rational? A comparison of the risk for second fracture versus death. J Am Med Dir Assoc. 2010;11:584-91.
22. Gosch M, Kammerlander C, Pils K, Lechleitner M, Benvenuti-Falger U, Roth T, Joosten-Gstrein B, Pietschmann P. [Osteoporotic treatment options in geriatric patients]. Z Gerontol Geriatr. 2012;45:417-28.
23. Gosch M, Kammerlander C, Roth T, Doshi HK, Gasser RW, Blauth M. Surgeons save bones: an algorithm for orthopedic surgeons managing secondary fracture prevention. Arch Orthop Trauma Surg. 2013;133:1101-8.
24. Bolland MJ, Avenell A, Baron JA, Grey A, MacLennan GS, Gamble GD, Reid IR. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ. 2010;341:c3691.
25. Bischoff-Ferrari HA, Willett WC, Orav EJ, Lips P, Meunier PJ, Lyons RA, Flicker L, Wark J, Jackson RD, Cauley JA, Meyer HE, Pfeifer M, Sanders KM, Stahelin HB, Theiler R, Dawson-Hughes B. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med. 2012;367:40-9. Erratum in: N Engl J Med. 2012 Aug 2;367:481.
26. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266-81.
27. Weycker D, Macarios D, Edelsberg J, Oster G. Compliance with drug therapy for postmenopausal osteoporosis. Osteoporos Int. 2006;17:1645-52.
28. Rizzoli R, Akesson K, Bouxsein M, Kanis JA, Napoli N, Papapoulos S, Reginster JY, Cooper C. Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report. Osteoporos Int. 2011;22:373-90.
29. Goldhahn J, Féron JM, Kanis J, Papapoulos S, Reginster JY, Rizzoli R, Dere W, Mitlak B, Tsouderos Y, Boonen S. Implications for fracture healing of current and new osteoporosis treatments: an ESCEO consensus paper. Calcif Tissue Int. 2012;90:343-53.
30. Eriksen EF, Lyles KW, Colón-Emeric CS, Pieper CF, Magaziner JS, Adachi JD, Hyldstrup L, Recknor C, Nordsletten L, Lavecchia C, Hu H, Boonen S, Mesenbrink P. Antifracture efficacy and reduction of mortality in relation to timing of the first dose of zoledronic acid after hip fracture. J Bone Miner Res. 2009;24:1308-13.
31. Peichl P, Holzer LA, Maier R, Holzer G. Parathyroid hormone 1-84 accelerates fracture-healing in pubic bones of elderly osteoporotic women. J Bone Joint Surg Am. 2011;93:1583-7.
32. Ettinger D, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA. 1999;282:637-45.
33. Rabar S, Lau R, O'Flynn N, Li L, Barry P; Guideline Development Group. Risk assessment of fragility fractures: summary of NICE guidance. BMJ. 2012; 345:e3698. doi: 10.1136/bmj.e3698.
34. Diez-Perez A, Adachi JD, Agnusdei D, Bilezikian JP, Compston JE, Cummings SR, Eastell R, Eriksen EF, Gonzalez-Macias J, Liberman UA, Wahl DA, Seeman E, Kanis JA, Cooper C. IOF CSA Inadequate Responders Working Group. Treatment failure in osteoporosis. Osteoporos Int. 2012;23:2769-74.